CTSZ and posterior cortical atrophy: For instance, proteomic analyses have identified CTSZ as a stratifying biomarker across different PCa Gleason grades (18), and its expression in peripheral blood has been proposed as a complementary biomarker to PSA for improving diagnostic accuracy and reducing unnecessary prostate biopsies (19).